Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,590.96 -66.12 -0.76%
TOPIX 720.23 -6.80 -0.94%
Hang Seng 19,055.50 +254.47 1.35%
Gold 1,555.30 +0.28%
EUR-USD 1.2463 -0.3205%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.57 -0.21%
U.S. 10-year 1.724% -0.014
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Fund Type: Open-End Fund
  • Objective: Blend - Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Large Cap Core Fund

Add to Portfolio

MALRX:US

11.61 USD 0.13 1.13%

As of 09:29:30 ET on 05/29/2012. Mutual Fund NAVs include dividends.

Snapshot for BlackRock Large Cap Core Fund (MALRX)

Year To Date: +3.70% 3-Month: -7.64% 3-Year: +12.47% 52-Week Range: 9.48 - 12.83
1-Month: -6.21% 1-Year: -7.12% 5-Year: -3.42% Beta vs RIY: 1.08

Mutual Fund Chart for MALRX

No chart data available.
  • MALRX:US 11.61
  • 1M
  • 1Y
Interactive MALRX Chart

Previous Close

Fund Profile & Information for MALRX

BlackRock Large Cap Core Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests, through a Master Portfolio, primarily in equity securities of large cap companies. The Fund will use an investment approach that blends growth and value.

Inception Date: 12-22-1999 Telephone: 1-800-441-7762
Managers: ROBERT C DOLL JR "BOB" / DANIEL HANSON
Web Site: www.blackrock.com

Fundamentals for MALRX

NAV (on 2012-05-29) 11.61
Assets (M) (on 2012-05-29) 1,648.59
Fund Leveraged N
Minimum Investment 2,000,000.00
Minimum Subsequent Investment 0.00

Dividends for MALRX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2011-12-14) 0.07
Dividend Yield (ttm) 0.59

Fees & Expenses for MALRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.47
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.05

Top Fund Holdings for MALRX

Filing Date: 12/31/2011
Name Position Value % of Total
Pfizer Inc 2,640,000 57,129,600 2.319%
Exxon Mobil Corp 670,000 56,789,200 2.305%
Philip Morris International In 660,000 51,796,800 2.103%
Apple Inc 120,000 48,600,000 1.973%
Bristol-Myers Squibb Co 1,040,000 36,649,600 1.488%
Amgen Inc 550,000 35,315,500 1.434%
UnitedHealth Group Inc 670,000 33,955,600 1.378%
Eli Lilly & Co 800,000 33,248,000 1.350%
Marathon Oil Corp 1,040,000 30,440,800 1.236%
WellPoint Inc 440,000 29,150,000 1.183%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements